To find the possible reason of the hypercoagulability in cancer patients with COVID-19, we analyzed the association of coagulation indexes and platelet parameters with the levels of CRP, PCT, IL-6, lymphocytes and PaO2 (Table 3). The gene discussed is CRP; the disease is thrombophilia.